What is the recommended management for irritable bowel syndrome?

Management of Irritable Bowel Syndrome

For patients under 45 years meeting diagnostic criteria without alarm features, make a positive IBS diagnosis and initiate a stepwise treatment approach starting with lifestyle modifications and dietary interventions, escalating to symptom-targeted pharmacotherapy, and reserving neuromodulators for refractory cases. 1

Initial Diagnosis and Assessment

Establish the diagnosis clinically without extensive testing in patients under 45 years who meet Rome criteria and lack alarm features (rectal bleeding, anemia, ≥5% unintended weight loss, nocturnal symptoms, fever, family history of colorectal cancer or inflammatory bowel disease). 2, 3

• Limit serologic testing to celiac disease antibodies only. 3, 4
• Avoid routine ordering of C-reactive protein, fecal calprotectin, IgG-based food allergy panels, or hydrogen breath testing for small intestinal bacterial overgrowth. 3, 4
• Reserve colonoscopy for patients with alarm features or IBS-D patients with atypical risk factors (age ≥50 years, female sex, autoimmune disease, recent onset <12 months, or NSAID/PPI use) to exclude microscopic colitis. 3

Step 1: Universal First-Line Interventions (All Patients)

Patient Education and Reassurance

• Explain IBS as a disorder of gut-brain interaction with a benign but relapsing/remitting course to establish realistic expectations. 2, 1
• Address patient concerns directly, identify their beliefs about the condition, and consider using a symptom diary to track triggers. 2, 1

Lifestyle Modifications

• Prescribe regular moderate-intensity physical activity to all patients, as this yields significant improvement in overall symptoms—particularly constipation—with benefits maintained for at least five years. 1, 3
• Recommend balanced diet with regular time for defecation and proper sleep hygiene. 2, 1

Initial Dietary Modifications

• For constipation-predominant IBS (IBS-C): Start soluble fiber (psyllium/ispaghula) at 3-4 g/day and titrate upward gradually to minimize bloating. 1, 3
• Avoid insoluble fiber (wheat bran) in all IBS subtypes as it consistently aggravates bloating and other symptoms. 1, 3
• For diarrhea-predominant IBS (IBS-D): Identify and reduce excessive intake of lactose, fructose, sorbitol, caffeine, or alcohol. 2, 1
• Do not recommend gluten-free diet unless celiac disease or non-celiac gluten sensitivity is confirmed. 1, 4

Step 2: Symptom-Targeted Pharmacotherapy (If Step 1 Fails After 4 Weeks)

For Abdominal Pain and Cramping

• Prescribe antispasmodics with anticholinergic properties (dicyclomine) as first-line therapy, particularly when symptoms are meal-related. 2, 1, 3
• Counsel patients about common side effects: dry mouth, visual disturbances, and dizziness. 1
• Consider peppermint oil as an alternative antispasmodic, though evidence is more limited. 1, 3

For Diarrhea-Predominant IBS (IBS-D)

• Prescribe loperamide 4-12 mg daily either regularly or prophylactically (before going out) to reduce stool frequency, urgency, and fecal soiling. 2, 1, 3
• Titrate dose carefully to avoid constipation, bloating, nausea, and abdominal pain. 1
• If loperamide fails, consider codeine 30-60 mg 1-3 times daily, though central nervous system effects often limit use. 2
• For patients with atypical features (nocturnal diarrhea, prior cholecystectomy), consider testing for bile acid malabsorption and trial cholestyramine, though it is often less well tolerated than loperamide. 2, 1

For Bloating

• Reduce intake of fiber, lactose, and fructose as relevant. 2, 1
• Trial probiotics for 12 weeks for global symptoms and bloating; discontinue if no improvement. 1, 3

Step 3: Advanced Dietary Intervention (If Step 2 Fails)

• Refer to a trained dietitian for a supervised low FODMAP diet delivered in three phases: (1) restriction for 4-6 weeks, (2) systematic reintroduction according to individual tolerance, and (3) personalized maintenance. 1, 3, 4
• This approach is particularly effective for moderate to severe symptoms but requires professional guidance to avoid nutritional deficits. 1

Step 4: Neuromodulators (For Mixed Symptoms or Refractory Pain After 12 Weeks)

Tricyclic Antidepressants (First-Line Neuromodulator)

• Start amitriptyline 10 mg once daily and titrate slowly to 30-50 mg once daily for mixed symptoms or refractory abdominal pain. 1, 5
• TCAs are the most effective first-line pharmacological treatment for global symptoms, abdominal pain, and mixed IBS, with moderate to high quality evidence. 1, 5
• TCAs are especially effective for patients with insomnia, though they may aggravate constipation. 2, 1
• Continue for at least 6 months if the patient reports symptomatic improvement. 1
• Counsel patients about the rationale for use (gut-brain neuromodulation, not depression treatment) and side-effect profile. 1

Selective Serotonin Reuptake Inhibitors (Alternative)

• Consider SSRIs if TCAs are not tolerated or if there is concurrent mood disorder requiring treatment. 2, 1
• Evidence for SSRIs is weaker than for TCAs. 1, 5
• Monitor carefully for anxiety and disturbed sleep. 1

Step 5: Psychological Therapies (For Symptoms Refractory to Pharmacotherapy for 12 Months)

• Consider IBS-specific cognitive behavioral therapy or gut-directed hypnotherapy when symptoms persist despite pharmacological treatment for 12 months. 1, 3
• These brain-gut behavior therapies are specifically designed for IBS and differ from psychological therapies that target depression and anxiety alone. 1
• Initially offer simple relaxation therapy using audiotapes before escalating to formal psychological interventions. 2, 1
• Consider biofeedback therapy specifically for patients with coexisting defecatory disorders or fecal incontinence. 1, 3

Multidisciplinary Care Coordination

• Build collaborative links with gastroenterology dietitians for FODMAP diet supervision and patients reporting considerable intake of trigger foods or dietary deficits. 1, 3
• Refer to a gastropsychologist if symptoms are moderate to severe, the patient accepts that symptoms relate to gut-brain dysregulation, and has time to devote to learning new coping strategies. 1

Treatment Monitoring and Adjustment

• Reassess treatment effectiveness after 3 months and discontinue ineffective medications. 1, 3
• Recognize that symptoms may relapse and remit over time, requiring periodic adjustment of treatment strategy. 1

Critical Pitfalls to Avoid

• Do not pursue extensive diagnostic testing in patients under 45 without alarm features, as this reinforces illness anxiety and adds unnecessary cost without benefit. 1, 3
• Do not order IgG-based food allergy panels, as true IgE-mediated food allergy is rare in IBS and such tests lack validity. 1, 3
• Do not use insoluble fiber (wheat bran) because it consistently worsens bloating and overall symptom burden. 1, 3
• Do not test for exocrine pancreatic insufficiency or perform hydrogen breath testing for small intestinal bacterial overgrowth in typical IBS presentations. 3
• Do not recommend loperamide, cholestyramine, or osmotic laxatives for overall IBS symptoms—use them only for specific symptom targets (diarrhea or constipation respectively). 4